Embed Size (px)
Citation preview
Poster Presentation List
November 2nd
Transplant Nursing
No.
(Abstract
Code)
Abstract Title
Presenting Author, Country
P001
(8971)
Improve patient quality of life by transplant nurse selection of venous access
for autologous haemopoietic stem cell transplant
Yuen Shing Wong/ Hong Kong
P002
(8936)
Implementation of a collection of blood stem cell medical and nursing care
process
Lee Chia Lien/ Taiwan
P003
(8932)
Fall risk assessment of adult inpatients with hematologic malignancies at
Blood Transfusion Hematology Hospital – Hochiminh City – Vietnam in 2018
Van Minh Huynh/ Vietnam
P004
(8916)
Improving the Management Quality of Graft-versus-Host Disease and
Infection for Hematopoietic Stem Cell Transplantation Survivors
Ying-Chih Huang/ Taiwan
P005
(8867)
The changes in knowledge before and immediately after education
workshops for LTFU and current stage of behavior change in Japan
Reiko Yamahana/ Japan
P006
(8839)
Prevention of perianal incontinence dermatitis in GVHD patients by cluster
intervention measures
Aiyun Jin, Xiaoyu Zhou/ China
P007
(8776)
REVIEW OF THE LITERATURE ON CARING FOR LONG TERM CENTRAL VENOUS
CATHETERS (CVCS) Le thi Son, MSN
Son Le Thi/ Vietnam
P008
(8775)
The Experience of Integrating Hospital-Based Palliative Consultation service to
a Young Adult Patient with Acute Lymphoblastic Leukemia during Terminal
Stage
Hui-Jen Hsieh/ Taiwan
P009
(8764)
Medical collaboration for long-term follow up of post-transplant patients at
the Non-transplant center
Miki Kondo/ Japan
P010
(8753)
Nutrition and Rehabilitation of Hematopoietic Stem Cell Transplantation
Patients
Hisayo Doi/ Japan
P011
(8747)
HSCT Long Term Follow Up Clinic – The Singapore General Hospital
Experience
Chung Cheng Hwang/ Singapore
P012
(8742)
Symptom Distress, Sense of Coherence and Quality of Life among Adult
Survivors Received Peripheral Blood Stem Cell Transplatation-A pilot study
Min-Chen Lee/ Taiwan
P013
(8625)
Survival of patients with hematological malignancies receiving hematopoietic
stem cell transplantation: Single center experience based on retrospective
analysis from case management
Yi-Tsui Wu/ Taiwan
P014
(8501)
One Stop Service for Patients Receiving Autologous Haemopoietic Stem Cell
Transplant
Yuen Bing Ng/ Hong Kong
P015
(8416)
Nursing care of 1 cases of capillary leak syndrome complicated with large
herpes zoster after allogeneic hematopoietic stem cell transplantation
Chen Xiaoli/ China
Alternative Stem Cell Sources / Histocompatibility
No.
(Abstract
Code)
Abstract Title
Presenting Author, Country
P016
(8979)
Transplant outcomes of haploidentical activities, GIAC-like versus PTCy-based,
for hematological malignancies in Taiwan: Results from Taiwan Blood and
Marrow Transplantation Registry (TBMTR)
Chi-Cheng Li/ Taiwan
P017
(8974)
The Frequency of Human Leukocyte Antigen (HLA) DP Alleles and Haplotypes
of HLA- DRB1, -DQB1 and DP in National Taiwan University hospital
Feiyun Liu/ Taiwan
P018
(8901)
HLA antigen and haplotype distribution in Malaysian candidates for
hematopoietic stem cell transplantation
Kevin Tey/ Malaysia
Clinical Cellular Therapy
No.
(Abstract
Code)
Abstract Title
Presenting Author, Country
P019
(8957)
Safety and efficacy of autologous CD19/CD22 dual targeted CAR-T therapy for
adult patients with relapsed/refractory B-cell malignancies
Yongxian Hu/ China
P020
(8924)
Gene therapy for major haemoglobin disorders through lentiviral vector
based gene transfer
Alok Srivastava/ India
Complications after HSCT, excluding GVHD
No.
(Abstract
Code)
Abstract Title
Presenting Author, Country
P021
(9001)
Adoptive donor immunity protects resolved HBV reactivation after allo-HSCT
in the world’s largest single center study
Jia Hau Liu/ Taiwan
P022
(8980)
Invasive Fungal Infections after Hematopoietic Stem Cell Transplantation in
Taiwan – Data from Taiwan Blood and Marrow Transplantation Registry
(TBMTR)
Bor-Sheng Ko/ Taiwan
P023
(8976)
Favorable long-term outcome of nephrotic syndrome in patients after
allogeneic hematopoietic stem cell transplantation.
Yamin Tan/ China
P024
(8954)
Effect of Immunoglobulin G2 subclass level on late-onset bacterial infection
after allogeneic hematopoietic stem cell transplantation
Rie Yamazaki/ Japan
P025
(8934)
Validation of recently proposed risk and prognostic factors for thrombotic
microangiopathy after allogeneic hematopoietic stem cell transplantation in
acute myeloid leukemia
Gi June Min/ Korea
P026
(8930)
Liver transplantation for the treatment of hepatic veno-occlusive disease
after allogeneic hematopoietic stem cell transplantation
Ka-Won Kang/ Korea
P027
(8918)
Repurposing nilotinib for cytomegalovirus infection prophylaxis after
allogeneic hematopoietic stem cell transplantation: a single-arm, phase 2 trial
Chien-ting Lin/ Taiwan
P028
(8897)
An Experience of Donor Lymphocyte Infusion after Reduced-intensity
Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Chronic
Granulomatous Disease
Tahereh Rostami/ Iran
Graft Processing
No.
(Abstract
Code)
Abstract Title
Presenting Author, Country
P029
(8961)
Plerixafor for mobilization of hematopoietic stem cells for autologous
transplantation in Japanese patients with non-Hodgkin lymphoma and
multiple myeloma
Jun Kato/ Japan
Graft-versus-Host disease / Graft-versus-Leukemia Effects
No.
(Abstract
Code)
Abstract Title
Presenting Author, Country
P030
(8928)
Ruxolitinib Combined With Etanercept for Patients With Corticosteroid-
refractory Acute Graft versus Host Disease After Allogeneic Stem Cell
Transplantation: A Multi-center Prospective Study
Yanmin Zhao/ China
P031
(8891)
IMPORTANCE OF PERIPHERAL BLOOD ABSOLUTE LYMPHOCYTE COUNTS (ALC)
IN PREDICTING TRANSPLANT OUTCOMES IN PREPARATIVE REGIMENS USING
ANTI-THYMOCYTE GLOBULIN OR ALEMTUZUMAB: AN INTERNATIONAL 2
CENTRE EXPERIENCE.
Vipul Sheth/ United Kingdom
P032
(8871)
nTreg and iTreg immunosuppressed functions are potently suppressed by the
Janus kinase 1/2 (JAK1/2) inhibitor Ruxolitinib in vitro
Xiaoqing Li, Yanmin Zhao, Yu Lin, He Huang/ China
P033
(8829)
Acute Graft-Vs-Host Disease(A-GVHD): Pathobiology and Management
Naser Shagerdi Esmaeli/ Iran
P034
(8792)
STEROID-REFRACTORY ACUTE GASTROINTESTINAL GRAFT VERSUS HOST
DISEASE (SRGVHD) SUCCESSFULLY TREATED WITH RUXOLITINIB: A CASE
REPORT
Feroni Pella Panjaitan/ Philippines
Other transplant-related Issues, e.g. Late Effects of Transplant,
Palliative Care No.
(Abstract
Code)
Abstract Title
Presenting Author, Country
P035
(8938)
Implementation of a State Wide Network for Quality Management and
Accreditation in Haemopoetic Progenitor Cell Transplant Laboratories and
Collection Centres.
Philip Rowlings/ Australia
P036
(8914)
Relationships between the Resilience and Quality of Life of Hematopoietic
Stem Cell Transplantation (HSCT) Survivors after discharge ~a pilot study
Jia Ying Wu, Lih Mih Chen/ Taiwan
P037
(8912)
Outcome and Risk Factors of Transplantation-associated Active Tuberculosis
in Allogeneic Haematopoietic Stem Cell Transplantation: A Nested Case
Control Study
Yanmin Zhao/ China
P038
(8909)
Evidence summary of management of nutrition support for adult patients
with hematopoietic stem cell transplantation
Yun Fang/ China
P039
(8908)
Donor with hypoplasia bone marrow meanwhile full blood count and other
examinations are normal can be used for patients receiving allogeneic
hematopoietic stem cell transplantation
Fei-Fei Tang/ China
P040
(8907)
TEN YEAR ACTIVITY AND OUTCOME DATA OF TRANSPLANTS FROM A
TERTIARY CANCER CENTRE IN INDIA
Avinash Bonda/ India
P041
(8905)
BPDCN─ a rare and agressive hematologic malignancy: 3 case reports
Ta-Chuan Yu/ Taiwan
P042
(8884)
Activity of the team SKiP (Supporting Kids Parents with Cancer)
Sakiko Kondo/ Japan
P043
(8845)
Quality Improvement Initiatives: Characteristics and Outcomes of
Haematopoietic Stem Cell Transplantation in Hong Kong
Pui-Yin Joycelyn Sim/ Hong Kong
P044
(8824)
A Case Study on Efficacy of episil® Oral Liquid on Reduction of Pain from Oral
Mucositis in Patients Received Hematopoietic Stem Cell Transplantation
Mio Nakagawa/ Japan
Pediatric Transplants No.
(Abstract
Code)
Abstract Title
Presenting Author, Country
P045
(8977)
Autologous Stem Cell Transplant in Pediatric Patients with Atypical Teratoid
Rhabdoid Tumor
Hsiu-Ju Yen/ Taiwan
P046
(8946)
Outcomes of Hematopoietic Stem Cell Transplantation in Primary
Immunodeficiency : The Experience from A Single Tertiary Center.
Chia-Jui Du/ Taiwan
P047
(8925)
Haematopoietic Stem Cell Transplantation in Acquired Severe Aplastic
Anaemia of Childhood: A Three-Year Experience from Sabah Women’s and
Children’s Hospital
Asohan Thevarajah/ Malaysia
P048
(8922)
A Novel reduced-intensity conditioning regimen containing cladribine for
allogeneic hematopoietic stem cell transplantation in pediatric patients with
major thalassemia
Lu Quanyi/ China
P049
(8902)
A Yearly Report of Primary Immunodeficiency Patients Treated with Reduced-
Intensity Conditioning Hematopoietic Stem Cell Transplantation at the Largest
Iranian Children’s Hospital
Amir Ali Hamidieh/ Iran
P050
(8893)
Transforming vision in to reality in a resource limited setting: establishing a
Pediatric Hematopoietic Stem cell Transplant unit through public private
partnership in India
Nikita Shah/ India
P051
(8888)
AN OUNCE OF PREVENTION AND A POUND OF CURE
Venkateswaran V S/ India
P052
(8886)
Pediatric blood transfusion practices at a regional referral hospital in Kenya
Emmanuel Akansugwina/ Kenya
P053
(8880)
What will be the fate of children and adolescents with idiopathic non-severe
aplastic anemia?
Hong Hoe Koo/ Korea
Stem Cell Biology / Hematopoiesis No.
(Abstract
Code)
Abstract Title
Presenting Author, Country
P054
(8967)
ENGRAFTMENT OF HEMATOPOIETIC STEM CELL TRANSPLANTATION WITH
CRYOPRESERVATION USING 5-PERCENT DIMETHYL SULFOXIDE AT –80°C WITH
UNCONTROLLED-RATE FREEZING PROTOCOL
Damai Santosa/ Indonesia
P055
(8948)
Ex Vivo Expansion of CD34+CD90+CD49f+ Hematopoietic Stem & Progenitor
Cells from Non-enriched Umbilical Cord Blood with Novel Azole Compounds
William Hwang/ Singapore
P056
(8947)
3D culture system mediated by self assembled polypeptide biomaterials
enhanced the amplification of mouse hematopoietic stem cell and progenitor
cell compared with 2D culture system
Wei Shan/ China
Transplantation for Benign Hematological and Other Diseases No.
(Abstract
Code)
Abstract Title
Presenting Author, Country
P057
(8942)
Stem Cell Transplant for Severe Aplastic Anemia in Pakistan; Data from a
developing country
Uzma Zaidi/ Pakistan
P058 Early outcome of matched unrelated donor haematopoietic stem cell
(8939) transplants for thalassaemia major performed at a single centre in Sri Lanka
Lallindra Gooneratne/ Sri Lanka
P059
(8937)
Feasible outcomes of hematopoietic stem cell transplantation with total
nodal irradiation and ATG conditioning for adult patients with severe aplastic
anemia despite severe comorbidity.
Kyoung Il Min/ Korea
P060
(8933)
Allogeneic bone marrow transplantation from unrelated donor for a patient
with idiopathic CD4+ lymphocytopenia
Michiko Ryuzaki/ Japan
Transplantation for Leukemia No.
(Abstract
Code)
Abstract Title
Presenting Author, Country
P061
(8966)
Clinical outcome of CLAG chemotherapy plus modified Bu/TBI conditioning
regimen for allogeneic hematopoietic stem cell transplantation patients with
acute leukemia and myelodysplastic syndrome
Wei Zhang/ China
P062
(8965)
A Retrospective Analysis of Allogeneic Hematopoietic Stem Cell
Transplantation for Chronic Myeloid Leukemia in TKI Era in Single Center
Wei Ma, Wei Zhang/ China
P063
(8953)
The efficacy and safety comparison between HLA-matched and HLA-
haploidentical allogeneic hematopoietic stem cell transplantation in adult
acute leukemia
Mei-Hui Chen/ Taiwan
P064
(8943)
A Success Allogeneic Sibling Peripheral Blood Stem Cell Transplantation in A
76-year-old Patient with Acute Myeloid Leukemia in Second Remission
Pei-Ying Hsieh/ Taiwan
P065
(8941)
Mutation analysis of six post-transplant relapsed acute myeloid leukemia and
suggestions for future incorporation of next-generation sequencing (NGS) into
precise diagnosis and treatment decision
Silvia Park/ Korea
P066
(8923)
Study of Haploidentical Stem Cell Transplantation for Philadelphia/BCR-ABL
Positive Acute Lymphoblastic Leukemia
Narendra Agrawal/ India
P067
(8921)
Low toxicity conditioning with Total Body Irradiation and Fludarabine with
post-transplant cyclophosphamide for allogeneic stem cell transplantation in
Acute lymphoblastic Leukemia
Narendra Agrawal/ India
P068
(8920)
Medium-dose VP-16 intensified conditioning regimen is effective in allogeneic
stem cell transplantation for acute lymphoblastic leukemia in CR1
Feifei Sun/ China
P069
(8910)
Impact of Remission Status on the Outcome of Hematopoietic Stem Cell
Transplantation for Acute Myeloid Leukemia
Garret Leung/ Hong Kong
P070
(8903)
Busulfan-containing conditioning regimens in allogeneic hematopoietic stem-
cell transplantation for acute lymphoblastic leukemia: Single tertiary center
experience in Taiwan
Yu-Hung Wang/ Taiwan
P071
(8895)
Long-term outcomes in patients with Acute Lymphoblastic Leukemia post
allogeneic transplant
Jeffrey Quek, Singapore
P072
(8860)
Treatment of refractory/relapsed acute myeloid leukemia (AML) with CLAG
regimen followed by allogeneic hematopoietic stem cell transplantation: A
report of three clinical cases
Jian Yu/ China
P073
(8858)
Progress of allogeneic transplantation at our hospital for 40 years; increasing
of older patients but decreasing in the rate of non-relapse mortality
Koichi Miyamura, Yoonha Lee/ Japan
Transplantation for Lymphoma/Myeloma No.
(Abstract
Code)
Abstract Title
Presenting Author, Country
P074
(9006)
Choosing the Induction Chemotherapy of Multiple Myeloma underwent
Autologous PBSCT in Surabaya: Effect on CD34+ Count, Engraftment Period
and Length of Stay
Merlyna Savitri/ Indonesia
P075
(9002)
Outcome of Bendamustine-Replacing BCNU as Conditioning Regimen for
Autologous Hematopoietic Cell Transplantation for Patients with Lymphoma
Tai-Yu Kuo, Ching-Liang Ho, Ming-Shen Dai, Ping-Ying Chang, Tzu-Chuan
Huang, Yi-Ying Wu, Jia-Hong Chen, Ren-Hua Ye, Shiue-Wei Lai, Yeu-Chin Chen/
Taiwan
P076
(8975)
Survival Analysis through Mantle Cell Lymphoma Risk Stratification and Stem
Cell Transplantation in the Era of Target Therapy – an observational cohort
study in Taiwan
Yu-Hung Wang/ Taiwan
P077
(8970)
Stem cell transplantation for T-cell lymphoma: data from Taiwan Society of
Blood and Marrow Transplantation
Ya-Ting Hsu/ Taiwan
P078
(8956)
Diagnostic challenge: Primary bone marrow diffuse large B-cell lymphoma
mimicking systemic autoimmune disorders.
Boyeon Kim, Joowon Oh/ Korea
P079
(8951)
Autologous stem cell transplantation in multiple myeloma: post-transplant
outcomes of Taiwan Blood and Marrow Transplantation Registry
Yi-Ying Wu/ Taiwan
P080
(8944)
High-dose Chemotherapy Followed by Autologous Stem Cell Transplantation
for Patients with Multiple Myeloma – Experience of a Single Medical Center in
Taiwan
Tung-Liang Lin/ Taiwan
P081
(8919)
Analysis of the efficacy and prognostic factors of 67 patients with multiple
myeloma after undergoing autologous peripheral hematopoietic stem cell
transplantation
Fangshu Guan/ China
P082
(8915)
Long-term Outcome of Hematopoietic Stem Cell Transplantation, a Two-
decade Retrospective Cohort in Phramongkutklao Hospital
Piyarat Pimsi/ Thailand
P083
(8892)
The efficacy of G-CSF mobilized, non-cryopreserved stem cell collection in the
same admission with autologous stem cell transplantation for multiple
myeloma
Adisak Tantiworawit/ Thailand
P084
(8881)
Outcome of Autologous stem cell transplantation in Multiple Myeloma, in the
Era of Novel agents: A Single centre Experience
Varun Bafna/ India
P085
(8848)
Trends in the use of autologous stem cell transplantation and survival after
transplant in multiple myeloma: A population-based study in Taiwan
Hsin-An Hou/ Taiwan
P086
(8846)
Thiotepa-Carmustine-Etoposide as Conditioning Therapy Before Autologous
Stem Cell Transplantation for Central Nervous System Non-Hodgkin
Lymphoma
Cheng Kiat Lawrence Ng/ Singapore
P087
(8841)
Outcomes of patients with multiple myeloma who underwent autologous
stem cell transplantation: A single-centre experience
Jeffrey Quek/ Singapore
Poster Presentation List
November 3rd
Alternative Stem Cell Sources / Histocompatibility
No.
(Abstract
Code)
Abstract Title
Presenting Author, Country
P088
(8889)
Comparison of Spectra Optia using continuous mononuclear cell protocol and
COBE Specra AutoPBSC apheresis system for peripheral blood stem cell
collection
Jeong-Shi Lin/ Taiwan
P089
(8794)
Total nucleated cell dose less than 2x107/kg in CBT predicts slower
engraftment but comparable incidence of neutrophil recovery to those who
received ≥2x107/kg
Naoyuki Uchida/ Japan
P090
(8779)
A single center experience of Haploidentical Haematopoietic Stem Cell
Transplant (HSCT) in Hong Kong
Joycelyn Sim/ China
P091
(8749)
Full-matched unrelated donor is considered an alternative choice rather than
sibling donor for elderly patients undergoing allogeneic hematopoietic stem
cell transplantation for acute leukemia and myelodysplastic syndrome
Sheng-Hsuan Chien/ Taiwan
P092
(8734)
High frequency of 0–1-antigen-mismatched donors among first-degree
relatives in Japan
Mizuki Watanabe/ Japan
P093
(8581)
GVHD prophylaxis using Tacrolimus + Mini-MTX in umbilical cord blood
transplantation
Souichi Shiratori/ Japan
Clinical Cellular Therapy
No.
(Abstract
Code)
Abstract Title
Presenting Author, Country
P094
(8896)
Gene therapy for hemophilia A using lentiviral vector-engineered CD34+
hematopoietic stem cells
Alok Srivastava/ India
P095
(8732)
Successful treatment of refractory cytomegalovirus colitis after haploidentical
hematopoietic stem cell transplantation using CD45RA+ depleted donor
lymphocyte infusion.
Hyoung Jin Kang/ Korea
Complications after HSCT, excluding GVHD
No.
(Abstract
Code)
Abstract Title
Presenting Author, Country
P096
(8890)
Successfully treat of severe hemorrhagic cystitis by intravesicle hyaluronic
acid in a case of haploidentical stem cell transplant-a case report
Ching-I Yang, Hui-hua Hsiao/ Taiwan
P097
(8859)
Establishment of novel monitoring assay, digital PCR, for HHV-6 reactivation
after allogeneic stem cell transplantation
Hitomi Nakayama/ Japan
P098
(8856)
A Prospective Observational Study of Incidence of Early Cytomegalovirus
Reactivation and Factors Affecting It Following Allogeneic Stem Cell
Transplantation
Bharat Ram/ India
P099
(8855)
Impact of donor-recipient ABO mismatch on outcomes in Allogeneic
Haematopoietic stem cell transplant - Indian multi-center data.
Sharat Damodar/ India
P100
(8818)
Evaluation of the bacterial and fungal infection status in hematopoietic stem
cell transplantation patients in HCMC Blood Transfusion and Hematology
Hospital.
Tuan Ma Xuan/ Vietnam
P101
(8801)
The impact of voriconazole antifungal prophylaxis after allogeneic
hematopoietic stem cell transplantation compared with fluconazole
Yuma Sakamoto/ Japan
P102
(8797)
Pooled Analysis of Studies of Defibrotide for the Treatment of Veno-occlusive
Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Hematopoietic
Stem Cell Transplantation (HSCT) or Chemotherapy Without HSCT
Richard Martin/ United Kindom
P103
(8795)
Hyperbaric Oxygen Therapy for Hemorrhagic Cystitis after the Allogeneic
Stem Cell Transplantation-A Case Report
Mehrdad Payandeh/ Iran
P104
(8783)
Validation of treatment outcomes according to revised EBMT severity criteria
for SOS/VOD: A multicenter retrospective study in Korea
Jae-Ho Yoon/ Korea
P105
(8766)
Management of Evans syndrome following cord blood stem cell
transplantation in severe aplastic anemia with rituximab
Hyera Kim/ Korea
P106
(8763)
The incidence of CMV reactivation and CMV diseases in the haplo-identical
hematopoietic stem cell transplantation – a single-center experience
Bor-Sheng Ko/ Taiwan
P107
(8760)
Risk factors for thrombotic microangiopathy and its impact on the outcome in
patients after allogeneic hematopoietic stem cell transplantation
Naoki Tamura/ Japan
P108
(8740)
Non-infectious neurological complications presenting with myelopathy and
neuropathy after umbilical cord blood transplantation
Michiho Ebihara/ Japan
P109
(8727)
Retrospective analysis of human herpes virus-6 (HHV-6) myelitis cases after
allogeneic hematopoietic stem cell transplantation
Kohei Shiroshita/ Japan
P110
(8475)
Pseudomonas aeruginosa refractory to treatment
Mehrdad Payandeh/ Iran
P111
(8465)
Evaluation of the association of CMV immunoglobulins (cytomegalovirus)
with transplantation time in patients with bone marrow transplantation in
Kermanshah
Mehrdad Payandeh/ Iran
P112
(8447)
The incidence and risk factors of hepatic veno-occlusive disease after
hematopoietic stem cell transplantation in Taiwan
Hsiu-Hao Chang/ Taiwan
Graft Processing
No.
(Abstract
Code)
Abstract Title
Presenting Author, Country
P113
(8927)
A pilot prospective single-arm clinical study on Decitabine plus CAG or IA
followed with HLA-mismatched nonmyeloablative transplantation (micro
transplantation) on de novo elderly Acute Myeloid Leukemia and Int-2/high
risk Myelodysplastic Syndrome patients
Jie Sun/ China
P114
(8575)
The effect of elapsed time and temperature on the viability and apoptosis of
CD34+ cells in the thawed and DMSO-repleted cord bloods
Young-Ho Lee/ Korea
Graft-versus-Host Disease / Graft-versus-Leukemia Effects
No.
(Abstract
Code)
Abstract Title
Presenting Author, Country
P115
(8790)
Occurrence and Severity of DLI associated Chronic GVHD Influence the
Clinical Outcomes in Relapsed Acute Leukemia after Allogeneic
Hematopoietic Stem Cell Transplantation
Wen-Jing Yu, Xiao-Dong Mo/ China
P116
(8744)
Graft-versus-host disease free, relapse-free survival after allogeneic stem cell
transplantation for myelodysplastic syndrome
Sung-Soo Park/ Korea
P117
(8628)
A mesenchymal stromal cell (MSC)-derived combination of CXCL5 and anti-
CCL24 is synergistic and superior to MSC and cyclosporine for the treatment
of graft-versus-host disease
Xiubo Fan/ Singapore
P118
(8407)
The Efficacy of Palifermin on Oral Mucositis and acute GVHD after
Hematopoietic Stem Cell Transplantation in Hematologic Malignancy Patients:
A Systematic Review and Meta-analysis study
Mehrdad Payandeh/ Iran
Other Transplant-related Issues, e.g. Late Effects Of Transplant,
Palliative Care No.
(Abstract
Code)
Abstract Title
Presenting Author, Country
P119
(8813)
STEM CELLS TRANSPORTATION FOR THE FIRST UNRELATED
TRANSPLANTATION IN VIETNAM
Van Minh Huynh/ Vietnam
P120 Treosulfan based conditioning in patients who are ineligible for standard
(8793) myeloablative conditioning
Jong Ho Won/ Korea
P121
(8781)
Nursing Leadership Challenges – Experiences of Patient Safety & Infection
Control for a Bone Marrow Transplantation Ward Restoration
Yu-Fang Chu/ Taiwan
P122
(8736)
The efficiency of PBSC harvest from family donor, Analysis based on a
National prospective Survey from 2000 to 2005.
Kana Nanato/ Japan
P123
(8728)
Cardiac output response to exercise after allogenic hematopoietic stem cell
transplantation: A case report with a 1-year follow-up
Shinya Yoshida/ Japan
P124
(8571)
Clinical effect of Power peripherally inserted central catheter and central
venous catheter in hematopoietic stem cell transplantation
Jing Wang/ China
P125
(8548)
Change of Supportive Care Needs and Related Factors in Patients Underwent
Hematopoietic Stem Cell Transplantation
Pei-Hsuan Lee/ Taiwan
P126
(8546)
Efficacy and safety of biosimilar filgrastim on unrelated cord blood
transplantation: a single-institutional retrospective analysis
Masaki Iino/ Japan
P127
(8523)
Proposing a New Nursing Informatics Model to Manageming Complexity
Zhila Saneipour/ Iran
P128
(8435)
Reviewing the performance of bone marrow transplantation unit in Imam
Reza hospital,Kermanshah,Iran
Mehrdad Payandeh/ Iran
Pediatric Transplants No.
(Abstract
Code)
Abstract Title
Presenting Author, Country
P129
(8878)
TREOSULFAN BASED CONDITIONING REGIMEN – REDUCED TOXICITY WITH
EXCELLENT OUTCOMES IN CHILDREN WITH PRIMARY IMMUNE DEFICIENCY
Venkateswaran V S/ India
P130
(8854)
Toxicity and efficacy of thiotepa, busulfan, fludarabine conditioning before
allogeneic stem cell transplantation in children with haematological
malignancies
Georgina Oakman/ Australia
P131
(8788)
Two different therapy-related acute myeloid leukemias following treatment of
immature teratoma in a pediatric patient with XYY syndrome: A case with
successful unrelated hematopoietic stem cell transplantation
Ho Sung Kim/ Korea
P132
(8787)
Successful allogeneic hematopoietic stem cell transplantation in a patient
with mixed phenotype acute leukemia and disseminated fusariosis: The
second case report and review of the literature
Ho Sung Kim/ Korea
P133
(8777)
Haploidentical Hematopoietic Stem Cell Transplantation in Pediatric Patients
– A single institution report in Taiwan
Shu-Wei Chou/ Taiwan
P134
(8752)
Haematopoietic stem cell transplantation for children with inherited bone
marrow failure syndromes: a single centre experience over 15 years from
India
Ramya Uppuluri/ India
P135
(8751)
Superior survival rates using peripheral blood stem cells in transplanting
children with acquired aplastic anaemia in developing countries: experience
over 15 years from a paediatric transplant unit in India
Ramya Uppuluri/ India
P136
(8750)
Disease free survival in paediatric malignant disorders with cost effective care
after haploidentical stem cell transplantation with post-transplant
cyclophosphamide: a single centre experience from south India
Ramya Uppuluri/ India
P137
(8737)
Hematopoietic stem cell transplantation for pediatric acute promyelocytic
leukemia in Japan: A nationwide retrospective study
Shohei Yamamoto/ Japan
P138
(8663)
Blinatumomab use in pediatric and adolescent patients with
relapsed/refractory B-precursor acute lymphoblastic leukemia from an open-
label, multicenter, expanded access study
Julia Li/ Hong Kong
P139
(8404)
Identifying important factors that influence the quality of life in survivors
after allogeneic bone marrow transplantation in childhood
Masami Inoue/ Japan
P140
(9044)
Haplo-identical Bone Marrow Transplantation with post-transplant
Cyclophosphamide in pediatric haematological disorders; A ray of hope in a
challenging situation
Saqib Hussain Ansari/ Pakistan
Stem Cell Biology / Hematopoiesis No.
(Abstract
Code)
Abstract Title
Presenting Author, Country
P141
(8883)
Glia Maturation Factor-γ Regulates hematopoietictic stem cell development
Honghu Li/ China
P142
(8661)
Wnt/β-catenin Signaling Pathway Regulates Neural Differentiation of Mouse
Induced Pluripotent Stem Cells in Vitro
Qin Yu/ China
P143
(8544)
DELETION 7q31 MYELODYSPLASTIC SYNDROME EVOLVING AFTER A
PREVIOUSLY DIAGNOSED SECONDARY PURE RED CELL APLASIA: A CASE
REPORT
Rhoderick Fusilero/ Philippines
P144
(8454)
Next-generation sequencing-based characterization of the invasion by
anatomical contiguity in a primary osseous diffuse large B-cell lymphoma.
Correlation between the genetic profile of the malignancy and the clinical
outcome of the patient
Ciprian Tomuleasa/ Romania
P145
(8406)
Stem cell mobilisation and Graft engineering
Mehrdad Payandeh/ Iran
Transplantation for Benign Hematological and Other Diseases No.
(Abstract
Code)
Abstract Title
Presenting Author, Country
P146
(8899)
Outcome of advanced myelofibrosis and myeloproliferative neoplasm treated
with allogeneic hematopoietic cell transplantation following reduced-
intensity conditioning regimens
Seug Yun Yoon/ Korea
P147
(8887)
ESTABLISHMENT OF HAPLOIDENTICAL TRANSPLANT PROGRAM IN PAKISTAN;
A REALISTIC SOLUTION TO OVERCOME DONOR SHORTAGE
Uzma Zaidi/ Pakistan
P148
(8872)
Myeloablative conditioning regimen and alternative donor hematopoietic
stem cell transplantation for paroxysmal nocturnal hemoglobinuria
Fang Xu, Zhicong Du, Gele Tong, Yun Wang, Yali Du, Xiaofan Jiang, Haiyan Hu,
Yue Lu/ China
P149 Long-term outcome of allogeneic hematopoietic stem cell transplantation
(8816) from HLA-matched sibling donor in young patients with acquired aplastic
anaemia at HCMC BTH
Ngon Huynh Thien, Man Huynh Van/ Vietnam
P150
(8803)
Peripheral Blood Stem Cell Transplantation in Aplastic Anemia Patients:
Comparable Results versus Conventional Bone Marrow Transplantation
Ardeshir Ghavamzadeh/ Iran
P151
(8743)
Hematopoietic stem cell transplant for aplastic anemia: A retrospective
analysis from a tertiary care center
Dharma Choudhary/ India
P152
(8741)
Allogeneic Hematopoietic Stem Cell Transplant for Myelofibrosis: A Single-
Center Experience in the Philippines
Preeti Prerna Vaswani/ Philippines
Transplantation for Leukemia No.
(Abstract
Code)
Abstract Title
Presenting Author, Country
P153
(8806)
The comparison between Umbilical cord blood transplantation and HLA-
identical sibling allo-PBSCT in the treatment of MDS-EB and AML-MRC
Zhu Jiang/ China
P154
(8799)
Comparable outcomes of myeloablative conditioning regimen without
antithymocyte globulin in CBT for pediatric patients with hematological
malignancies with a weight of more than 30 kilograms vs. less than 30
kilograms
Chenhui Luo/ China
P155
(8784)
Impact of gene mutations on overall survival of allogenic hematopoietic stem
cell transplantation for high risk acute myeloid leukemia in complete
remission
Fang Xu, Yue Lu, Yanli Zhao, Jianping Zhang, Min Xiong, Xingyu Cao, Deyan Liu,
Ruijuan Sun, Zhijie Wei, Jiarui Zhou/ China
P156
(8782)
Haploidentical Hematopoietic Stem Cell Transplant for Acute leukemia: A
Single Center Experience
Dharma Choudhary, India
P157
(8774)
The Treatment Outcomes of Hematopoietic Stem Cell Transplantation
According to Donor Types in Elderly Patients with Acute Myeloid Leukemia
Byung Sik Cho, Korea
P158
(8768)
Prognostic impact of cytogenetic abnormalities on outcome of allogeneic
hematopoietic stem cell transplantations for adults with acute myeloid
leukemia – a single institute analysis of 320 recipients
Mitsuhiro Yuasa/ Japan
P159
(8754)
Adult acute megakaryoblastic leukemia: rare association with cytopenias of
undetermined significance and p210 and p190 BCR-ABL transcripts, prior to
allogeneic stem cell transplantation
Ciprian Tomuleasa/ Romania
P160
(8739)
The efficacy analysis of allogeneic hematopoietic stem cell transplantation in
48 leukemia patients with central nervous system leukemia
Xinhong Fei, Jingbo Wang/ China
P161
(8724)
Prophylactic donor lymphocyte infusion for patients with advanced acute
leukemia after allogeneic hematopoietic stem cell transplantation：an
efficacy and safety analysis.
luxin Yang/ China
P162
(8681)
Long-Term Survival of Adults With B-Cell Precursor Acute Lymphoblastic
Leukemia (BCP-ALL) After Treatment With Blinatumomab And Subsequent
Allogeneic Hematopoietic Stem Cell Transplantation
Julia Li/ Hong Kong
P163
(8678)
AlloHSCT in Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia
Treated with Blinatumomab vs Standard-of-Care Chemotherapy from a
Randomized Phase 3 Study
Julia Li/ Hong Kong
P164
(8513)
Evaulation of relapse and its treatment following Allogenic Stem Cell
Transplantation (ASCT) for Acute Myeloid Leukaemia (AML)
Ajay Gupta/ India
Transplantation for Lymphoma/Myeloma No.
(Abstract
Code)
Abstract Title
Presenting Author, Country
P165
(8828)
Allogeneic hematopoietic stem cell transplantation for multiple myeloma: A
single-center experience
Ting-An Lin/ Taiwan
P166
(8807)
Clinical outcomes of allogeneic stem cell transplantation with reduced
intensity conditioning method with FluMel-TBI regimen in refractory or
relapsed non-Hodgkin lymphoma
Seok-Goo Cho, Young-Woo Jeon/ Korea
P167
(8780)
Acute GVHD following Autologous Stem Cell Transplant for Multiple
Myeloma:A case series
Divya Doval/ India
P168
(8769)
The First 12 Months Transplant Activity and Outcome Report at The 1st
National Haematopoetic Stem Cell Transplant (HSCT) Centre in Sri Lanka
Prasad Abeysinghe/ Sri Lanka
P169
(8767)
The Safety and Efficacy of Plerixafor and G-CSF for Autologous Stem Cell
Mobilization in Patients with Malignant Lymphoma and Multiple Myeloma
Shinichiro Oshima/ Japan
P170
(8765)
Optimal chemo-mobilization for peripheral blood stem cell collection in
multiple myeloma
Je-Jung Lee/ Korea
P171
(8762)
Bendamustine as a salvage therapy in peritransplant setting in hodgkin
lymphoma - a single institutional experience
Kartthik Shanmugam/ India
P172
(8651)
Hematopoietic Stem Cell Transplantation for Mantle Cell Lymphoma in Taiwan
Tran-Der Tan/ Taiwan
P173
(8533)
Successful management with tandem auto-allo hematopoietic stem cell
transplantation for a double-hit diffuse large B cell lymphoma with primary
treatment failure
Woei-Yau Kao/ Taiwan
P174
(8436)
Upfront autologous stem cell transplantation for newly diagnosed elderly
multiple myeloma patients
Mehrdad Payandeh/ Iran
